The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
ImmunityBio, Inc(NASDAQ:IBRX) 
ImmunityBio, Inc., an immunotherapy company, develops a memory T-cell cancer vaccine to combat multiple tumor types without the use of high-dose chemotherapy. It develops an albumin-linked chemotherapeutic therapy (Aldoxorubicin), a novel IL-15 cytokine superagonist (N-803), checkpoint inhibitors, m...
Share this website to your friends
ImmunityBio Days Payable Outstanding ttm (DPO)
ImmunityBio Days Receivable Outstanding ttm (DSO)
ImmunityBio Days Inventory Outstanding ttm (DIO)
ImmunityBio Op Cashflow Per Share ttm
ImmunityBio Free Cashflow Per Share ttm
ImmunityBio Cash Per Share ttm
ImmunityBio P/S ratio ttm
ImmunityBio (GAAP) P/E ratio ttm
ImmunityBio P/B ratio ttm
No extra charts and metrics for this ticker.